Titre : Cellules souches totipotentes

Cellules souches totipotentes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Young Adult
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cellules souches totipotentes : Questions médicales les plus fréquentes", "headline": "Cellules souches totipotentes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cellules souches totipotentes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-02", "dateModified": "2025-02-27", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cellules souches totipotentes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cellules souches", "url": "https://questionsmedicales.fr/mesh/D013234", "about": { "@type": "MedicalCondition", "name": "Cellules souches", "code": { "@type": "MedicalCode", "code": "D013234", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.872" } } }, "about": { "@type": "MedicalCondition", "name": "Cellules souches totipotentes", "alternateName": "Totipotent Stem Cells", "code": { "@type": "MedicalCode", "code": "D039901", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peng Du", "url": "https://questionsmedicales.fr/author/Peng%20Du", "affiliation": { "@type": "Organization", "name": "MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing 100871, China; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China. Electronic address: pengdu@pku.edu.cn." } }, { "@type": "Person", "name": "Maria-Elena Torres-Padilla", "url": "https://questionsmedicales.fr/author/Maria-Elena%20Torres-Padilla", "affiliation": { "@type": "Organization", "name": "Institute of Epigenetics and Stem Cells (IES), Helmholtz Zentrum München, 81377 München, Germany." } }, { "@type": "Person", "name": "Sergio Ruiz", "url": "https://questionsmedicales.fr/author/Sergio%20Ruiz", "affiliation": { "@type": "Organization", "name": "Laboratory of Genome Integrity, CCR, NCI, NIH, Bethesda, MD 20814, U.S.A." } }, { "@type": "Person", "name": "Mohammad H Ghazimoradi", "url": "https://questionsmedicales.fr/author/Mohammad%20H%20Ghazimoradi", "affiliation": { "@type": "Organization", "name": "Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran." } }, { "@type": "Person", "name": "Hui Shen", "url": "https://questionsmedicales.fr/author/Hui%20Shen", "affiliation": { "@type": "Organization", "name": "MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing 100871, China; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Myeloproliferative neoplasms in adolescents and young adults.", "datePublished": "2022-08-14", "url": "https://questionsmedicales.fr/article/36333071", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.beha.2022.101374" } }, { "@type": "ScholarlyArticle", "name": "Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.", "datePublished": "2022-05-19", "url": "https://questionsmedicales.fr/article/35521712", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1530/EJE-21-1104" } }, { "@type": "ScholarlyArticle", "name": "Adolescent and Young Adult Communication Preferences.", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36383117", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1089/jayao.2022.0087" } }, { "@type": "ScholarlyArticle", "name": "Thoughts of young adults with Down syndrome.", "datePublished": "2022-07-09", "url": "https://questionsmedicales.fr/article/36428048", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.apnu.2022.06.006" } }, { "@type": "ScholarlyArticle", "name": "Adrenal crises in adolescents and young adults.", "datePublished": "2022-05-18", "url": "https://questionsmedicales.fr/article/35583847", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12020-022-03070-3" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Cellules souches", "item": "https://questionsmedicales.fr/mesh/D013234" }, { "@type": "ListItem", "position": 4, "name": "Cellules souches totipotentes", "item": "https://questionsmedicales.fr/mesh/D039901" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cellules souches totipotentes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cellules souches totipotentes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cellules souches totipotentes", "description": "Comment identifier les cellules souches totipotentes ?\nQuels tests sont utilisés pour les cellules souches ?\nLes cellules souches totipotentes sont-elles rares ?\nPeut-on isoler des cellules souches totipotentes ?\nQuelles sont les caractéristiques des cellules totipotentes ?", "url": "https://questionsmedicales.fr/mesh/D039901?mesh_terms=Young+Adult&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cellules souches totipotentes", "description": "Quels symptômes sont associés aux cellules souches ?\nLes cellules souches totipotentes causent-elles des maladies ?\nY a-t-il des signes de dysfonctionnement cellulaire ?\nLes cellules souches totipotentes sont-elles liées à des cancers ?\nComment les cellules souches affectent-elles le développement ?", "url": "https://questionsmedicales.fr/mesh/D039901?mesh_terms=Young+Adult&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cellules souches totipotentes", "description": "Comment prévenir les anomalies liées aux cellules souches ?\nY a-t-il des facteurs environnementaux à éviter ?\nLes habitudes alimentaires influencent-elles les cellules souches ?\nLes vaccinations affectent-elles les cellules souches ?\nComment le stress maternel impacte-t-il le développement ?", "url": "https://questionsmedicales.fr/mesh/D039901?mesh_terms=Young+Adult&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cellules souches totipotentes", "description": "Les cellules souches totipotentes sont-elles utilisées en thérapie ?\nQuels traitements impliquent des cellules souches ?\nPeut-on utiliser des cellules souches pour régénérer des tissus ?\nY a-t-il des risques associés aux traitements par cellules souches ?\nLes cellules souches totipotentes peuvent-elles traiter des maladies ?", "url": "https://questionsmedicales.fr/mesh/D039901?mesh_terms=Young+Adult&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cellules souches totipotentes", "description": "Quelles complications peuvent survenir avec les cellules souches ?\nLes cellules souches peuvent-elles causer des tumeurs ?\nY a-t-il des risques d'infections avec les cellules souches ?\nComment gérer les complications liées aux cellules souches ?\nLes complications sont-elles fréquentes avec les cellules souches ?", "url": "https://questionsmedicales.fr/mesh/D039901?mesh_terms=Young+Adult&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cellules souches totipotentes", "description": "Quels facteurs augmentent le risque d'anomalies ?\nLes maladies maternelles influencent-elles les cellules souches ?\nL'exposition à des toxines est-elle un facteur de risque ?\nLe mode de vie maternel impacte-t-il les cellules souches ?\nLes traitements médicaux peuvent-ils affecter les cellules souches ?", "url": "https://questionsmedicales.fr/mesh/D039901?mesh_terms=Young+Adult&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les cellules souches totipotentes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification se fait par des tests de différenciation et des marqueurs spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour les cellules souches ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de culture cellulaire et des analyses génétiques sont couramment utilisés." } }, { "@type": "Question", "name": "Les cellules souches totipotentes sont-elles rares ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont présentes uniquement dans les premiers stades de développement embryonnaire." } }, { "@type": "Question", "name": "Peut-on isoler des cellules souches totipotentes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'isolement est complexe et généralement réalisé en laboratoire sur des embryons." } }, { "@type": "Question", "name": "Quelles sont les caractéristiques des cellules totipotentes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent se différencier en tous les types de cellules, y compris les tissus embryonnaires." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux cellules souches ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les cellules souches elles-mêmes n'ont pas de symptômes, mais leur dysfonction peut affecter le développement." } }, { "@type": "Question", "name": "Les cellules souches totipotentes causent-elles des maladies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles ne causent pas de maladies, mais leur dérégulation peut entraîner des anomalies." } }, { "@type": "Question", "name": "Y a-t-il des signes de dysfonctionnement cellulaire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes peuvent inclure des malformations congénitales ou des troubles de développement." } }, { "@type": "Question", "name": "Les cellules souches totipotentes sont-elles liées à des cancers ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne causent pas de cancers, mais des cellules souches mal régulées peuvent contribuer à leur formation." } }, { "@type": "Question", "name": "Comment les cellules souches affectent-elles le développement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont essentielles pour le développement normal des tissus et organes embryonnaires." } }, { "@type": "Question", "name": "Comment prévenir les anomalies liées aux cellules souches ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne santé maternelle et des soins prénatals peuvent aider à prévenir les anomalies." } }, { "@type": "Question", "name": "Y a-t-il des facteurs environnementaux à éviter ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les toxines et les radiations peut réduire le risque d'anomalies embryonnaires." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les cellules souches ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir le développement cellulaire sain pendant la grossesse." } }, { "@type": "Question", "name": "Les vaccinations affectent-elles les cellules souches ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccinations sont importantes pour la santé maternelle et n'affectent pas les cellules souches." } }, { "@type": "Question", "name": "Comment le stress maternel impacte-t-il le développement ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut affecter le développement embryonnaire, il est donc important de le gérer." } }, { "@type": "Question", "name": "Les cellules souches totipotentes sont-elles utilisées en thérapie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elles ne sont pas encore utilisées en thérapie, mais la recherche est prometteuse." } }, { "@type": "Question", "name": "Quels traitements impliquent des cellules souches ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux utilisent des cellules souches pluripotentes, mais pas totipotentes." } }, { "@type": "Question", "name": "Peut-on utiliser des cellules souches pour régénérer des tissus ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les cellules souches peuvent potentiellement régénérer des tissus, mais pas encore avec des totipotentes." } }, { "@type": "Question", "name": "Y a-t-il des risques associés aux traitements par cellules souches ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des réactions immunitaires et des tumeurs, surtout avec des cellules mal différenciées." } }, { "@type": "Question", "name": "Les cellules souches totipotentes peuvent-elles traiter des maladies ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Elles ont un potentiel théorique, mais leur utilisation clinique est encore à l'étude." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les cellules souches ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des malformations ou des troubles de développement si mal régulées." } }, { "@type": "Question", "name": "Les cellules souches peuvent-elles causer des tumeurs ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des cellules souches mal différenciées peuvent entraîner la formation de tumeurs." } }, { "@type": "Question", "name": "Y a-t-il des risques d'infections avec les cellules souches ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les procédures d'isolement et de culture peuvent comporter des risques d'infection." } }, { "@type": "Question", "name": "Comment gérer les complications liées aux cellules souches ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une surveillance étroite et des interventions précoces sont essentielles pour gérer les complications." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes avec les cellules souches ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, surtout dans des contextes expérimentaux." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'anomalies ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge maternel avancé et des antécédents familiaux peuvent augmenter le risque." } }, { "@type": "Question", "name": "Les maladies maternelles influencent-elles les cellules souches ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme le diabète peuvent affecter le développement embryonnaire." } }, { "@type": "Question", "name": "L'exposition à des toxines est-elle un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des toxines environnementales peut augmenter le risque d'anomalies." } }, { "@type": "Question", "name": "Le mode de vie maternel impacte-t-il les cellules souches ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme et l'alcool peuvent nuire au développement des cellules souches." } }, { "@type": "Question", "name": "Les traitements médicaux peuvent-ils affecter les cellules souches ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certains traitements, comme la chimiothérapie, peuvent nuire au développement embryonnaire." } } ] } ] }

Sources (10000 au total)

Hypertriglyceridemia in young adults with a 22q11.2 microdeletion.

Mild to moderate hypertriglyceridemia is a condition often associated with obesity and diabetes, with as yet incomplete knowledge of underlying genetic architecture. The 22q11.2 microdeletion is assoc... This was a cohort study comparing 6793 population-based adults and 267 with a 22q11.2 microdeletion aged 17-69 years, excluding those with diabetes or on statins.... We used binomial logistic regression modeling to identify predictors of hypertriglyceridemia, accounting for the 22q11.2 microdeletion, male sex, BMI, ethnicity, age, and antipsychotic medications.... The 22q11.2 microdeletion was a significant independent predictor of mild to moderate hypertriglyceridemia (odds ratio (OR): 2.35, 95% CI: 1.70-3.26). All other factors examined were also significant ... The 22q11.2 microdeletion is associated with hypertriglyceridemia even when accounting for other known risk factors for elevated triglycerides. This effect is seen in young adulthood (76.6% were <40 y...

Thoughts of young adults with Down syndrome.

This study aimed to obtain information about the thoughts of young adults with Down syndrome through interviews of them.... The numbers of participants were 4 and 7 in order to group interviews and individual interviews. They were recruited through the local Association of Parents of Down syndrome. The study incorporated a... Through analysis, six themes emerged: 1) thoughts about work, 2) existence of friends, 3) how to spend leisure time, 4) meaning of disability, 5) relationships with people, and 6) future dreams.... 1) Although young adults with Down syndrome are serious about their work, it is difficult for them to make friends at work. However, they recognized people at work as their comrades and were encourage...

Adrenal crises in adolescents and young adults.

Review the literature concerning adrenal insufficiency (AI) and adrenal crisis (AC) in adolescents and young adults.... Searches of PubMed identifying relevant reports up to March 2022.... AI is rare disorder that requires lifelong glucocorticoid replacement therapy and is associated with substantial morbidity and occasional mortality among adolescents and young adults. Aetiologies in t... In this review, we examine the current state of knowledge of AC epidemiology in emerging adults; examine the causes of ACs in this age group; and suggest areas for further investigation that are aimed...

Ischemic Stroke in Young Tunisian Adults.

Ischemic Stroke in young adults is a real public health problem; it's a major cause of disability, alters quality of life and has a great socio-economic impact.... determine risk factors and specify the etiology of arterial ischemic stroke in young Tunisian adults.... In this 5 years retrospective study (2015-2020), we included all young adults (18-50 years) admitted for arterial ischemic stroke (AIS). Risk factors were registered and analyzed. All patients were in... We collected 200 patients with AIS. The mean age was 41.37 years ± 6.99. Traditional vascular risk factors were observed in more than 1⁄4 patients. A definite cause of stroke was identified in 120 pat... Through this study, we demonstrated the diversity of etiology of stroke in young Tunisian adults. Changes of lifestyle are responsible for the occurrence of the traditional risk factors at an early ag...

Primary Hyperparathyroidism in Young Adult Patients.

Primary hyperparathyroidism (PHPT) affects 2% of Americans over 55 years of age, and is less common in younger patients. Pediatric PHPT patients have higher rates of multigland disease (MGD). We studi... Retrospective chart review was performed on patients who underwent parathyroidectomy for PHPT (2000-2019). Cohorts were defined by age: Group A (18-40 years) and Group B (> 40 years). Univariate and m... Of 3889 patients with PHPT, 9.1% (n = 352) were included in Group A. On multivariate analysis, multiple endocrine neoplasia (odds ratio [OR] 6.3, 95% confidence interval [CI] 3.1-12.7), male sex (OR 1... In our population of patients with sporadic PHPT, a positive family history of PHPT was strongly associated with MGD; additional associations were found with prior parathyroidectomy, non-localizing im...